{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T04:49:24Z","timestamp":1775278164811,"version":"3.50.1"},"reference-count":19,"publisher":"Japanese Society of Internal Medicine","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026,4,1]]},"DOI":"10.2169\/internalmedicine.5910-25","type":"journal-article","created":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T22:07:52Z","timestamp":1757542072000},"page":"1043-1048","source":"Crossref","is-referenced-by-count":1,"title":["Agranulocytosis Following Durvalumab Plus Tremelimumab Therapy for Hepatocellular Carcinoma"],"prefix":"10.2169","volume":"65","author":[{"given":"Genta","family":"Uchida","sequence":"first","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Toyota Kosei Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junji","family":"Hiraga","sequence":"additional","affiliation":[{"name":"Department of Hematology, Toyota Kosei Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyoshi","family":"Morita","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Toyota Kosei Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsufumi","family":"Takeuchi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Toyota Kosei Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitomi","family":"Takashi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Toyota Kosei Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Furune","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Toyota Kosei Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoyuki","family":"Tsuzuki","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Toyota Kosei Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Kudo M. Immune checkpoint inhibition in hepatocellular carcinoma: basics and ongoing clinical trials. Oncology 92 (Suppl 1): 50-62, 2017.","DOI":"10.1159\/000451016"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Abou-Alfa GK, Lau G, Kudo M, et al. Tremelimumab plus durvalumab in unresectable hepatocellular carcinoma. NEJM Evid 1: EVIDoa2100070, 2022.","DOI":"10.1056\/EVIDoa2100070"},{"key":"3","unstructured":"3. The Japan Society of Hepatology. Clinical Practice Guidelines for Hepatocellular Carcinoma 2023 version. 5th ed. Kanehara Shuppan, Tokyo, 2023: 208-216 (in Japanese)."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Schneider BJ, Naidoo J, Santomasso BD, et al. Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: ASCO guideline update. J Clin Oncol 39: 4073-4126, 2021.","DOI":"10.1200\/JCO.21.01440"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Davis EJ, Salem JE, Young A, et al. Hematologic complications of immune checkpoint inhibitors. Oncologist 24: 584-588, 2019.","DOI":"10.1634\/theoncologist.2018-0574"},{"key":"6","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1186\/s12885-020-06763-y","volume":"20","author":"J Boegeholz","year":"2020","unstructured":"6. Boegeholz J, Brueggen CS, Pauli C, et al. Challenges in diagnosis and management of neutropenia upon exposure to immune-checkpoint inhibitors: meta-analysis of a rare immune-related adverse side effect. BMC Cancer 20: 300, 2020.","journal-title":"BMC Cancer","ISSN":"https:\/\/id.crossref.org\/issn\/1471-2407","issn-type":"print"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Lewis JH, Stine JG. Review article: prescribing medications in patients with cirrhosis - a practical guide. Aliment Pharmacol Ther 37: 1132-1156, 2013.","DOI":"10.1111\/apt.12324"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Kudo M. Scientific rationale for combination immunotherapy of hepatocellular carcinoma with anti-PD-1\/PD-L1 and anti-CTLA-4 antibodies. Liver Cancer 8: 413-426, 2019.","DOI":"10.1159\/000503254"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Khoja L, Day D, Wei-Wu Chen T. Tumour- and class-specific patterns of immune-related adverse events of immune checkpoint inhibitors: a systematic review. Ann Oncol 28: 2377-2385, 2017.","DOI":"10.1093\/annonc\/mdx286"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Qin Y, Lu S, Chen J, Peng J, Yang J. Case report: a rare case of anti-PD-1 sintilimab-induced agranulocytosis\/severe neutropenia in non-small cell lung cancer and literature review. Front Oncol 14: 1415748, 2024.","DOI":"10.3389\/fonc.2024.1415748"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Tong X, Zhan T, Dong X, Xu D. Fever of unknown origin associated with immune checkpoint inhibitors. Front Immunol 15: 1364128, 2024.","DOI":"10.3389\/fimmu.2024.1364128"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Finkel I, Sternschuss M, Wollner M, et al. Immune-related neutropenia following treatment with immune checkpoint inhibitors. J Immunother 43: 67-74, 2020.","DOI":"10.1097\/CJI.0000000000000293"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Jalil A, Zaffar J, Waqas A, Butt S. Isolated neutropenia due to immune checkpoint inhibitors. Cureus 15: e45674, 2023.","DOI":"10.7759\/cureus.45674"},{"key":"14","doi-asserted-by":"publisher","unstructured":"14. Frickhofen N, Heimpel H, Kaltwasser JP, Schrezenmeier H. Antithymocyte globulin with or without cyclosporin A: 11-year follow-up of a randomized trial comparing treatments of aplastic anemia. Blood 101: 1236-1242, 2003.","DOI":"10.1182\/blood-2002-04-1134"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Ban-Hoefen M, Burack R, Sievert L, Sahasrabudhe D. Ipilimumab-induced neutropenia in melanoma. J Investig Med High Impact Case Rep 4: 2324709616661835, 2016.","DOI":"10.1177\/2324709616661835"},{"key":"16","unstructured":"16. Xu F, Chen ZL, Jin WJ, Xie QD, Shi XH. Ideal therapeutic range of cyclosporine in whole blood in kidney-transplanted patients. Int J Clin Pharmacol Res 13: 221-224, 1993."},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Klein M, Radhakrishnan J, Appel G. Cyclosporine treatment of glomerular diseases. Annu Rev Med 50: 1-15, 1999.","DOI":"10.1146\/annurev.med.50.1.1"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Mandal PK, Baul S, Dolai TK, De R, Chakrabarti P. Outcome of cyclosporine monotherapy in patients of aplastic anemia: experience of a tertiary care hospital in eastern India. Indian J Hematol Blood Transfus 33: 144-147, 2017.","DOI":"10.1007\/s12288-016-0706-7"},{"key":"19","unstructured":"19. Nakao S, Ohtake S, Shiobara S, Mori T, Matsuda T. [Cyclosporin therapy for aplastic anemia]. Rinsho Ketsueki (Jpn J Clin Hematol) 31: 1450-1455, 1990 (in Japanese)."}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/7\/65_5910-25\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T03:55:01Z","timestamp":1775274901000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/7\/65_5910-25\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,1]]},"references-count":19,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.5910-25","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,1]]},"article-number":"5910-25"}}